Literature DB >> 10482432

Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy.

C M Maguire1, D H Crawford, L F Hourigan, A D Clouston, E T Walpole, E E Powell.   

Abstract

This report describes the case of a 53-year-old woman who developed severe hepatitis following chemotherapy for breast carcinoma. The patient was hepatitis B surface antigen positive, e antigen negative and e antibody positive and had high levels of hepatitis B virus-DNA. Liver biopsy revealed submassive hepatic necrosis, consistent with reactivation of hepatitis B. Treatment with lamivudine resulted in rapid loss of hepatitis B virus-DNA, resolution of hepatitis and clinical recovery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482432     DOI: 10.1046/j.1440-1746.1999.01961.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  2 in total

1.  Hepatitis B reactivation after chemotherapy: two decades of clinical research.

Authors:  George K K Lau
Journal:  Hepatol Int       Date:  2008-03-05       Impact factor: 6.047

2.  Fatal outcome of SARS in a patient with reactivation of chronic hepatitis B.

Authors:  Alex Y Hui; Henry L Y Chan; Choong-Tsek Liew; Paul K S Chan; Ka-Fai To; Chin-Pang Chan; Joseph J Y Sung
Journal:  Am J Med       Date:  2003-09       Impact factor: 4.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.